Time：2026-01-27 Reading volume:
Chemical engineering design manufacturers believe that with the continuous development of medical technology in China, the pharmaceutical and chemical industry has become a global hotspot. Among them, biotechnology is gradually shifting from medicine to chemical industry, changing the traditional chemical industry and gradually turning to biopharmaceuticals.
Chemical engineering design manufacturers believe that with the continuous development of medical technology in China, the pharmaceutical and chemical industry has become a global hotspot. Among them, biotechnology is gradually shifting from medicine to chemical industry, changing the traditional chemical industry and gradually turning to biopharmaceuticals.
Affected by population growth and the gradual popularization of economic development in developing countries, the development speed of emerging pharmaceutical markets is faster than that of developed countries. China is the leader in the emerging pharmaceutical market, contributing to the growth of the main pharmaceutical market and accounting for approximately 20% of the global pharmaceutical market.
The chemical engineering design manufacturer believes that with the in-depth promotion of the action plan of "Internet drug circulation", the pharmaceutical e-commerce industry will gradually enter the innovative development stage of transformation and upgrading. Driven by Internet technology, we will actively integrate social resources, develop platform models, provide new supply chain services for upstream and downstream enterprises, and provide professional services and intimate drug buying experience for patients by using new technologies such as big data, Internet of Things, cloud computing, etc.
The chemical engineering design manufacturer believes that an intelligent service platform for the pharmaceutical supply chain integrating Internet technology, pharmaceutical professional logistics, supply chain finance, and new pharmaceutical retail will be built to achieve industrial and commercial collaboration, product supervision collaboration, pharmaceutical collaboration, marketing collaboration, and logistics collaboration, reduce circulation costs internally, and expand terminal coverage externally. The electronic prescription platform is integrated into the hospital information system, and the drug data platform converts prescriptions into orders, supporting various ways of purchasing drugs such as in hospital delivery and home delivery.
Chemical engineering design manufacturers believe that in recent years, under the macroeconomic regulation of multiple healthcare reform policies, new policies and pilot work for separating medicine and pharmaceuticals have continued, and prescription outflow is a major trend. Under the new process of prescription outflow in the future, patients can choose to purchase drugs from retail or platforms after obtaining a prescription. The diversion of prescription drugs from traditional hospital sales channels to retail channels is expected to release a market of 100 billion yuan, which will bring huge opportunities for pharmaceutical e-commerce.
Chemical engineering design manufacturers believe that in the future, with the support of cloud computing, big data, and Internet of Things technology, large national pharmaceutical groups and regional pharmaceutical circulation leading enterprises will actively integrate resources in the upstream and downstream links of the supply chain, promote the integration of "logistics, information flow, and capital flow", and establish a diversified and collaborative pharmaceutical supply chain system. Large and medium-sized pharmaceutical distribution enterprises continuously optimize and upgrade their pharmaceutical logistics dismantling technology, cold chain box turnover system, and full process logistics visualization information system. Building an information-based intelligent supply chain.
Chemical engineering design manufacturers believe that the upstream of pharmaceutical intermediates is the basic chemical raw material industry, and basic chemical raw materials are bulk commodities with significant price fluctuations, directly affecting the production costs of enterprises. However, pharmaceutical intermediates are further divided into primary intermediates and intermediates. Due to the fact that first tier intermediate suppliers can only provide simple intermediate production and are at the forefront of the industry chain, there is significant competition and price pressure. The fluctuation of basic chemical raw material prices has a significant impact on it.
Mobile Website
Copyright © 2026 Xinhua Design&Engineering All rights reserved Record number: 鲁ICP备11005142号
Technical Support: WDL
